Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Continuous Interscalene Brachial Plexus Block With 0.125% Bupivacaine Versus 0.2% Ropivacaine on Diaphragmatic Motility and Ventilatory Function

NCT02059070 is registered in ClinicalTrials.gov with Anesthesiology WSU/DMC-NorthStar as lead sponsor.

NCT NCT02059070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02059070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Continuous Interscalene Brachial Plexus Block With 0.125% Bupivacaine Versus 0.2% Ropivacaine on Diaphragmatic Motility and Ventilatory Function
Lead sponsor
Anesthesiology WSU/DMC-NorthStar
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
June 30, 2013
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paresis